Consultation to remove glucagon-like-peptide-1 (GLP-1) receptor agonist analogues from the pharmacist extemporaneous compounding exemption
Published
Related content
-
Update on the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) pharmacy compounding changes
Amendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6) have been made resulting in compounded GLP-1 RA products no longer being able to be compounded by pharmacists and supplied to patients. -
Search warrant executed on South Yarra pharmacy
Therapeutic goods and records have been seized from a pharmacy in Melbourne. This is part of our investigation into the alleged unlawful manufacture, supply and export of therapeutic goods. -
Declaration that certain sports supplements are therapeutic goods
The TGA has made a section 7 declaration to declare that certain sports supplements are therapeutic goods